Enliven Therapeutics, Inc. (ELVN)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS29337E1029
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Enliven Therapeutics, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 21:08. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 02 Mar 2027 16:00 | -0.45 | — | — | Upcoming |
| 05 Nov 2026 16:00 | -0.43 | -0.36 | +16.9% | Beat |
| 05 Aug 2026 16:00 | -0.38 | -0.49 | -29.8% | Miss |
| 07 May 2026 16:00 | -0.41 | -0.38 | +7.3% | Beat |
| 03 Mar 2026 16:00 | -0.47 | -0.48 | -1.1% | Miss |
| 12 Nov 2025 16:00 | -0.46 | -0.32 | +31.2% | Beat |
| 13 Aug 2025 16:00 | -0.42 | -0.49 | -16.7% | Miss |
| 14 May 2025 16:00 | -0.50 | -0.57 | -13.0% | Miss |
| 13 Mar 2025 16:00 | -0.52 | -0.46 | +11.1% | Beat |
| 13 Nov 2024 16:00 | -0.50 | -0.48 | +4.4% | Beat |
| 13 Aug 2024 16:00 | -0.56 | -0.41 | +27.1% | Beat |
| 14 May 2024 16:00 | -0.57 | -0.54 | +4.7% | Beat |
| 14 Mar 2024 16:00 | -0.54 | -0.47 | +13.0% | Beat |
| 09 Nov 2023 16:00 | -0.47 | -0.51 | -7.9% | Miss |
| 10 Aug 2023 16:00 | -0.40 | -0.41 | -3.4% | Miss |
| 11 May 2023 16:00 | -0.52 | -0.80 | -53.9% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 0 | — | -103.7M | — | -1.83 | +3.2% | -70.5M |
| 2024 | 0 | — | -89M | — | -1.89 | +6.0% | -73.2M |
| 2023 | 0 | — | -71.6M | — | -2.01 | -119.3% | -61.4M |
| 2022 | 0 | — | -37.7M | — | -0.92 | — | -32.7M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 50.69 | 50.76 | 48.02 | 48.31 | -5.63% | 623,096 | |
| 11 Nov 2026 | 51.46 | 52.23 | 51.01 | 51.19 | -0.02% | 781,500 | |
| 10 Nov 2026 | 50.08 | 51.81 | 49.74 | 51.20 | -0.68% | 951,100 | |
| 09 Nov 2026 | 49.88 | 51.86 | 48.76 | 51.55 | +4.29% | 697,200 | |
| 06 Nov 2026 | 46.19 | 49.66 | 44.55 | 49.43 | +10.36% | 969,600 | |
| 05 Nov 2026 | 47.10 | 47.73 | 44.60 | 44.79 | -5.21% | 1,585,900 | |
| 04 Nov 2026 | 45.74 | 47.31 | 44.21 | 47.25 | +5.40% | 2,707,300 | |
| 03 Nov 2026 | 45.25 | 45.90 | 44.63 | 44.83 | +0.45% | 2,125,500 | |
| 02 Nov 2026 | 44.48 | 45.06 | 43.22 | 44.63 | +0.86% | 1,138,600 | |
| 30 Oct 2026 | 44.92 | 45.87 | 44.09 | 44.25 | -1.84% | 1,237,000 | |
| 1,245 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Enliven Therapeutics Stock In Focus After Wider Loss And FDA Trial Alignment (opens in a new tab) Simply Wall St. · 07 Nov 2026 16:13
- Guggenheim Reiterates Buy on Enliven Therapeutics, Maintains $78 Price Target (opens in a new tab) Benzinga · 06 Nov 2026 12:26
- Enliven Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Business Update (opens in a new tab) 05 Nov 2026 21:05
- Why Enliven Therapeutics' (ELVN) ENABLE-2 Trial Design Raises New Questions About Its CML Strategy (opens in a new tab) Simply Wall St. · 10 Oct 2026 05:20
- Halozyme prevails in patent fight with Merck; Enliven readies anticipated leukemia trial (opens in a new tab) BioPharma Dive · 07 Oct 2026 16:21
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 51.19 USD
- Market cap
- 3.6B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow ELVN and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.